These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 35325550)

  • 41. Editorial response to Cosentino and Marino RE: detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination.
    Stafford LS; Valcarce V; Henry M; Neu J; Parker L; Mueller M; Vicuna V; Gowen T; Cato E; Kosik I; Yewdell JW; Atkinson M; Cacho N; Li N; Larkin J
    J Perinatol; 2023 Jun; 43(6):828-829. PubMed ID: 37024528
    [No Abstract]   [Full Text] [Related]  

  • 42. Characterization of SARS-CoV-2 antibodies in human milk from 21 women with confirmed COVID-19 infection.
    Bode L; Bertrand K; Najera JA; Furst A; Honerkamp-Smith G; Shandling AD; Chambers CD; Camerini D; Campo JJ
    Pediatr Res; 2023 May; 93(6):1626-1633. PubMed ID: 36434204
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human Milk Antibodies Against SARS-CoV-2: A Longitudinal Follow-Up Study.
    Juncker HG; Romijn M; Loth VN; Caniels TG; de Groot CJM; Pajkrt D; van Gils MJ; van Goudoever JB; van Keulen BJ
    J Hum Lact; 2021 Aug; 37(3):485-491. PubMed ID: 34308720
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antibodies in the breastmilk of COVID-19 recovered women.
    Szczygioł P; Łukianowski B; Kościelska-Kasprzak K; Jakuszko K; Bartoszek D; Krajewska M; Królak-Olejnik B
    BMC Pregnancy Childbirth; 2022 Aug; 22(1):635. PubMed ID: 35953773
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Durable antibody and effector memory T cell responses in breastmilk from women with SARS-CoV-2.
    Narayanaswamy V; Pentecost BT; Telfer JC; Burnside AS; Schneider SS; Alfandari D; Baker RL; Saiju A; Nodiff S; Arcaro KF
    Front Immunol; 2022; 13():985226. PubMed ID: 36172379
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safety and Efficacy of Coronavirus Disease 2019 (COVID-19) mRNA Vaccines During Lactation.
    Shook LL; Edlow AG
    Obstet Gynecol; 2023 Mar; 141(3):483-491. PubMed ID: 36649326
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Persistence of COVID-19 Human Milk Antibodies After Maternal COVID-19 Vaccination: Systematic Review and Meta-Regression Analysis.
    Hamouda NI; Amin AM; Hasan MT; Baghagho E
    Cureus; 2024 May; 16(5):e59500. PubMed ID: 38826925
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers.
    Demers-Mathieu V; DaPra C; Mathijssen G; A Sela D; M Jarvinen K; Seppo A; Fels S; Medo E
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572480
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Response and Duration of Serum Anti-SARS-CoV-2 Antibodies After Inactivated Vaccination Within 160 Days.
    Xu QY; Xue JH; Xiao Y; Jia ZJ; Wu MJ; Liu YY; Li WL; Liang XM; Yang TC
    Front Immunol; 2021; 12():786554. PubMed ID: 35003104
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SARS-CoV-2 RNA and antibody detection in breast milk from a prospective multicentre study in Spain.
    Bäuerl C; Randazzo W; Sánchez G; Selma-Royo M; García Verdevio E; Martínez L; Parra-Llorca A; Lerin C; Fumadó V; Crovetto F; Crispi F; Pérez-Cano FJ; Rodríguez G; Ruiz-Redondo G; Campoy C; Martínez-Costa C; Collado MC;
    Arch Dis Child Fetal Neonatal Ed; 2022 Mar; 107(2):216-221. PubMed ID: 34417223
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Maternal vaccination as an additional approach to improve the protection of the nursling: Anti-infective properties of breast milk.
    Zheng Y; Correa-Silva S; Palmeira P; Carneiro-Sampaio M
    Clinics (Sao Paulo); 2022; 77():100093. PubMed ID: 35963149
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In response to Detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination.
    Cosentino M; Marino F
    J Perinatol; 2023 Jun; 43(6):827. PubMed ID: 37185365
    [No Abstract]   [Full Text] [Related]  

  • 53. SARS-CoV-2 spike RBD-specific IgA and IgG antibodies in breast milk after vaccination with the protein subunit vaccine Abdala.
    Pérez-Bernal M; Hernández C; Ibargollín R; Martínez M; Soria M; Delgado M; Valdivia O; Dorta D; Domínguez A; Pérez E; Cabrera Y
    Infect Med (Beijing); 2022 Dec; 1(4):253-261. PubMed ID: 38013910
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-Spike Antibodies Present in the Milk of SARS-CoV-2 Vaccinated Mothers Are Complement-Activating.
    Agostinis C; Toffoli M; Balduit A; Mangogna A; Yasmin H; Ragazzon C; Pegoraro S; Campisciano G; Stabile G; Zito G; Kishore U; Comar M; Scrimin F; Bulla R; Ricci G
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901824
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine.
    Choi JH; Kim YR; Heo ST; Oh H; Kim M; Lee HR; Yoo JR
    Front Immunol; 2022; 13():827306. PubMed ID: 35173736
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibody Responses to BNT162b2 Vaccination in Japan: Monitoring Vaccine Efficacy by Measuring IgG Antibodies against the Receptor-Binding Domain of SARS-CoV-2.
    Fujigaki H; Yamamoto Y; Koseki T; Banno S; Ando T; Ito H; Fujita T; Naruse H; Hata T; Moriyama S; Takahashi Y; Suzuki T; Murakami T; Yoshida Y; Yagura Y; Oyamada T; Takemura M; Kondo M; Iwata M; Saito K
    Microbiol Spectr; 2022 Feb; 10(1):e0118121. PubMed ID: 35044205
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.
    Schrezenmeier E; Bergfeld L; Hillus D; Lippert JD; Weber U; Tober-Lau P; Landgraf I; Schwarz T; Kappert K; Stefanski AL; Sattler A; Kotsch K; Dörner T; Sander LE; Budde K; Halleck F; Kurth F; Corman VM; Choi M
    Front Immunol; 2021; 12():690698. PubMed ID: 34276681
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immune Response of Neonates Born to Mothers Infected With SARS-CoV-2.
    Conti MG; Terreri S; Piano Mortari E; Albano C; Natale F; Boscarino G; Zacco G; Palomba P; Cascioli S; Corrente F; Capponi C; Mirabella M; Salinas AF; Marciano A; De Luca F; Pangallo I; Quaranta C; Alteri C; Russo C; Galoppi P; Brunelli R; Perno CF; Terrin G; Carsetti R
    JAMA Netw Open; 2021 Nov; 4(11):e2132563. PubMed ID: 34730817
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IgG and IgA Antibodies Post SARS-CoV-2 Vaccine in the Breast Milk and Sera of Breastfeeding Women.
    Scrimin F; Campisciano G; Comar M; Ragazzon C; Davanzo R; Quadrifoglio M; Giangreco M; Stabile G; Ricci G
    Vaccines (Basel); 2022 Jan; 10(1):. PubMed ID: 35062786
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Maternal, Infant, and Breast Milk Antibody Response Following COVID-19 Infection in Early Versus Late Gestation.
    Wachman EM; Snyder-Cappione J; Devera J; Boateng J; Dhole Y; Clarke K; Yuen RR; Parker SE; Hunnewell J; Ferraro R; Jean-Sicard S; Woodard E; Cruikshank A; Sinha B; Bartolome R; Barnett ED; Yarrington C; Taglauer ES; Sabharwal V
    Pediatr Infect Dis J; 2023 Mar; 42(3):e70-e76. PubMed ID: 36729773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.